Multi-PAP: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy

NCT02866799 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 593

Last updated 2020-08-06

No results posted yet for this study

Summary

This study assesses the effectiveness of a complex intervention in young-old patients with multimorbidity and polypharmacy aimed at improving physician drug prescription in primary care, measured by means of the Medication Appropriateness Index (MAI)-score at six 6 (T1) and 12 (T2) months from baseline compared to usual care.

Conditions

  • Multimorbidity
  • Polypharmacy
  • Other Diagnoses, Comorbidities, and Complications

Interventions

OTHER

Multi-PAP

Complex intervention based on the ARIADNE principles with two main components: 1) Training of general practitioners and 2) Patient centered clinical interview.

OTHER

Usual care

Patients will receive the usual clinical care based on current clinical practice guidelines.

Sponsors & Collaborators

  • Gerencia de Atención Primaria, Madrid

    collaborator OTHER_GOV
  • Aragon Institute for Health Research (IIS Aragón)

    collaborator UNKNOWN
  • Andaluz Health Service

    collaborator OTHER_GOV
  • Red de Investigación en Servicios de Salud en Enfermedades Crónicas

    collaborator OTHER
  • Instituto de Salud Carlos III

    collaborator OTHER_GOV
  • Instituto Aragones de Ciencias de la Salud

    lead OTHER_GOV

Principal Investigators

  • Alexandra Prados-Torres, MD, PhD · Instituto Aragonés de Ciencias de la Salud (IACS)

  • Daniel Prados-Torres, MD, PhD · Servicio Andaluz de Salud (Andaluz Health Service)

  • Isabel Del Cura-González, MD, PhD · Gerencia de Atención Primaria, Madrid

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02866799 on ClinicalTrials.gov